Grace Therapeutics, Inc. (GRCE)

SEC filing

Grace Therapeutics, Inc.

GRCE · CIK 1444192

4/A · Oct 1, 2026 · 10% Owner Opaleye Management Inc. bought 15.09K Common Stock, par value $0.0001 per share at $2.10/unit ($31,687)

4/A

10% Owner Opaleye Management Inc. bought 15.09K Common Stock, par value $0.0001 per share at $2.10/unit ($31,687)

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).